Long-term outcomes of autologous skeletal myoblast cell-sheet transplantation for end-stage ischemic cardiomyopathy
Satoshi Kainuma(National Cerebral and Cardiovascular Center), Yoshiki Sawa(Osaka Police Hospital), Toru Kuratani, Takuji Kawamura(The University of Osaka), Fusako Sera(The University of Osaka), Köichi Toda(The University of Osaka), Yoshito Ito(Kyoto Prefectural University of Medicine), Shigeru Miyagawa(The University of Osaka), Yasushi Sakata(Osaka University), Kei Nakamoto(The University of Osaka), Hiroko Iseoka, Ai Kawamura(Max Planck Institute for Heart and Lung Research), Takayoshi Ueno, Daisuke Yoshioka(The University of Osaka), Hiroki Hata(The University of Osaka), Noriyuki Kashiyama(The University of Osaka), Tomomi Yamada(Osaka University Hospital), Yasushi Yoshikawa(The University of Osaka), Tomohito Ohtani(The University of Osaka)
Cited by 36
Related Papers
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
|Nature Medicine|2022|889
Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases
|Nature Genetics|2020|599
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
|Circulation Journal|2020|363